The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Hypertension Awareness, Treatment, and Control in Adults With CKD: Results From the Chronic Renal Insufficiency Cohort (CRIC) Study
Open accessAbstract
Background A low rate of blood pressure control has been reported in patients with chronic kidney disease (CKD). These data were derived from population-based samples with a low rate of CKD awareness.Study design Cross-sectional.Setting & participants Data from the baseline visit of the Chronic Renal Insufficiency Cohort (CRIC) Study (n = 3,612) were analyzed. Participants with an estimated glomerular filtration rate of 20-70 mL/min/1.73 m(2) were identified from physician offices and review of laboratory databases.Outcomes Prevalence and awareness of hypertension, treatment patterns, control rates, and factors associated with hypertension control.Measurements Following a standardized protocol, blood pressure was measured 3 times by trained staff, and hypertension was defined as systolic blood pressure > or =140 mm Hg and/or diastolic blood pressure > or =90 mm Hg and/or self-reported antihypertensive medication use. Patients' awareness and treatment of hypertension were defined using self-report, and 2 levels of hypertension control were evaluated: systolic/diastolic blood pressure <140/90 and <130/80 mm Hg.Results The prevalence of hypertension was 85.7%, and 98.9% of CRIC participants were aware of this diagnosis and 98.3% were treated with medications, whereas 67.1% and 46.1% had hypertension controlled to <140/90 and <130/80 mm Hg, respectively. Of CRIC participants with hypertension, 15%, 25%, 26%, and 32% were using 1, 2, 3, and > or =4 antihypertensive medications, respectively. After multivariable adjustment, older patients, blacks, and those with higher urinary albumin excretion were less likely, whereas participants using angiotensin-converting enzyme inhibitors and angiotensin receptor blockers were more likely to have controlled their hypertension to <140/90 and <130/80 mm Hg.Limitations Data were derived from a single study visit.Conclusions Despite almost universal hypertension awareness and treatment in this cohort of patients with CKD, rates of hypertension control were suboptimal.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Difficulty controlling BP in late stages of CKD was also seen in CRIC (Chronic Renal Insufficiency Cohort), in which 88% of participants had stage 3 or 4 CKD.”
From Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association (2018) · cites this paper as [303]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, Ö., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,772
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
Prevalence of Chronic Kidney Disease in the United States
Coresh, J., Selvin, E., Stevens, L. A., Manzi, J., Kusek, J. W., Eggers, P., Van Lente, F., & Levey, A. S. (2007) · JAMA · doi:10.1001/jama.298.17.2038 · Cited by 4,895
Effect of Aerobic Exercise on Blood Pressure: A Meta-Analysis of Randomized, Controlled Trials
Whelton, S. P., Chin, A., Xin, X., & He, J. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-7-200204020-00006 · Cited by 1,970
Predictors of New-Onset Kidney Disease in a Community-Based Population
Fox, C. S. (2004) · JAMA · doi:10.1001/jama.291.7.844 · Cited by 1,241
Whelton, P. K., Appel, L. J., Espeland, M. A., Applegate, W. B., Ettinger, Jr., Kostis, J. B., Kumanyika, S., Lacy, C. R., Johnson, K. C., Folmar, S., et al. (1998) · JAMA · doi:10.1001/jama.279.11.839 · Cited by 1,200
Effects of Alcohol Reduction on Blood Pressure: A Meta-Analysis of Randomized Controlled Trials
Xin, X., He, J., Frontini, M. G., Ogden, L. G., Motsamai, O. I., & Whelton, P. K. (2001) · Hypertension · doi:10.1161/hy1101.093424 · Cited by 738
The Chronic Renal Insufficiency Cohort (CRIC) Study
Feldman, H. I., Appel, L. J., Chertow, G. M., Cifelli, D., Čižman, B., Daugirdas, J. T., Fink, J. C., Franklin-Becker, E. D., Go, A. S., Hamm, L. L., et al. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000070149.78399.ce · Cited by 660
Self-citationPrevalence of High Blood Pressure and Elevated Serum Creatinine Level in the United States
Coresh, J., Wei, G. L., McQuillan, G. M., Brancati, F., Levey, A. S., Jones, C. A., & Klag, M. J. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.9.1207 · Cited by 579
Traditional and Nontraditional Risk Factors Predict Coronary Heart Disease in Chronic Kidney Disease
Muntner, P., He, J., Astor, B. C., Folsom, A. R., & Coresh, J. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004080656 · Cited by 490
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 423
Hypertensive chronic kidney disease in African Americans: Strategies for improving care
Martins, D., Agodoa, L. Y. C., & Norris, K. C. (2012) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.79a.11109 · Cited by 33
Sodium and Volume Disorders in Advanced Chronic Kidney Disease
Khan, S. F., Floris, M., Pani, A., & Rosner, M. H. (2016) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2015.12.003 · Cited by 33
Hypertension in Chronic Kidney Disease: An Update on Diagnosis and Management
Gupta, A., Nagaraju, S. P., Bhojaraja, M. V., Swaminathan, S. M., & Mohan, P. B. (2023) · Southern Medical Journal · doi:10.14423/smj.0000000000001516 · Cited by 31
Loutradis, C., Price, A. M., Ferro, C. J., & Sarafidis, P. A. (2021) · Journal of Human Hypertension · doi:10.1038/s41371-021-00504-9 · Cited by 31
Zhang, W., Shi, W., Liu, Z., Gu, Y., Chen, Q., Yuan, W., Zhang, Y., Gong, L., Zhou, R., Li, M., et al. (2016) · Scientific Reports · doi:10.1038/srep38768 · Cited by 31
Vidal‐Petiot, E., Metzger, M., Faucon, A., Boffa, J., Haymann, J., Thervet, É., Houillier, P., Géri, G., Stengel, B., Vrtovsnik, F., et al. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.010278 · Cited by 30
Edwards, C., Hundemer, G. L., Petrcich, W., Canney, M., Knoll, G. A., Burns, K. D., Bugeja, A. L., & Sood, M. M. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.23365 · Cited by 29
Konta, T., Ikeda, A., Ichikawa, K., Fujimoto, S., Iseki, K., Moriyama, T., Yamagata, K., Tsuruya, K., Yoshida, H., Asahi, K., et al. (2011) · American Journal of Hypertension · doi:10.1038/ajh.2011.217 · Cited by 30
Yan, Z., Wang, Y., Li, S., Wang, J., Zhang, L., Tan, H., Li, S., Yang, L., Pei, H., Zhang, L., et al. (2018) · American Journal of Hypertension · doi:10.1093/ajh/hpx222 · Cited by 30
Circadian blood pressure patterns and blood pressure control in patients with chronic kidney disease
Daniele, N. D., Fegatelli, D. A., Rovella, V., Castagnola, V., Gabriele, M., & Scuteri, A. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.10.031 · Cited by 29
Heo, B. M., & Ryu, K. H. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15112571 · Cited by 32
Masked Hypertension in CKD: Increased Prevalence and Risk for Cardiovascular and Renal Events
Babu, M., & Drawz, P. E. (2019) · Current Cardiology Reports · doi:10.1007/s11886-019-1154-4 · Cited by 33
“Masked hypertension is typically seen in about 8–20% of the general population who are not on antihypertensive therapy [19–22]. A meta-analysis of 36 studies incorporating 25,629 patients estimated the prevalence of masked hypertension to be about 19% among adults [23]. The prevalence of masked hypertension is likely…”
Blood Pressure and Chronic Kidney Disease Progression: An Updated Review
Habas, E. M., Habas, E., Khan, F. Y., Rayani, A., Habas, A., Errayes, M., Farfar, K. L., & Elzouki, A.-N. Y. (2022) · Cureus · doi:10.7759/cureus.24244 · Cited by 29
Hypertension in Moderate-to-Severe Nondiabetic CKD Patients
Segura, J., & Ruilope, L. M. (2011) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2010.11.001 · Cited by 29
Surrogate Markers of Cardiovascular Disease in CKD: What's Under the Hood?
Rubin, M. F., Rosas, S. E., Chirinos, J. A., & Townsend, R. R. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2010.08.030 · Cited by 27
Self-citationThe relationship of volume overload and its control to hypertension in hemodialysis patients
Flythe, J. E., & Bansal, N. (2019) · Seminars in Dialysis · doi:10.1111/sdi.12838 · Cited by 30
Pewowaruk, R. J., Korcarz, C. E., de Boer, I. H., Kestenbaum, B. R., Heckbert, S. R., Tedla, Y. G., & Gepner, A. D. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.027517 · Cited by 27
Management of hypertension in patients with chronic kidney disease
Hamrahian, S. M. (2017) · Current Hypertension Reports · doi:10.1007/s11906-017-0739-9 · Cited by 26
Thomas, G., & Drawz, P. E. (2018) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.12551117 · Cited by 26
Magvanjav, O., Cooper‐DeHoff, R. M., McDonough, C. W., Gong, Y., Segal, M. S., Hogan, W. R., & Johnson, J. A. (2018) · Journal of Clinical Hypertension · doi:10.1111/jch.13429 · Cited by 24
Barrett, T. M., Green, J. A., Greer, R. C., Ephraim, P. L., Peskoe, S. B., Pendergast, J., Hauer, C. L., Strigo, T. S., Norfolk, E. R., Bucaloiu, I. D., et al. (2020) · Kidney Medicine · doi:10.1016/j.xkme.2020.05.008 · Cited by 25
Vaccarin alleviates hypertension and nephropathy in renovascular hypertensive rats
Cai, W., Zhang, Z., Huang, Y., Sun, H., & Qiu, L. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.5442 · Cited by 25
DASH Diet and Blood Pressure Among Black Americans With and Without CKD: The Jackson Heart Study
Tyson, C. C., Davenport, C. A., Lin, P., Scialla, J. J., Hall, R. K., Diamantidis, C. J., Lunyera, J., Bhavsar, N. A., Rebholz, C. M., Pendergast, J., et al. (2019) · American Journal of Hypertension · doi:10.1093/ajh/hpz090 · Cited by 28
Impact of multimorbidity on risk and outcome of stroke: Lessons from chronic kidney disease
Kelly, D., & Rothwell, P. M. (2020) · International Journal of Stroke · doi:10.1177/1747493020975250 · Cited by 24
Resistant hypertension: consensus document from the Korean society of hypertension
Park, S., Shin, J., Ihm, S., Kim, K., Kim, H., Kim, H. C., Lee, E. M., Lee, J. H., Ahn, S. Y., Cho, E. J., et al. (2023) · Clinical Hypertension · doi:10.1186/s40885-023-00255-4 · Cited by 26
Cardiorenal Syndrome Type 4: Management
Clementi, A., Virzì, G. M., Brocca, A., de Cal, M., Vescovo, G., Granata, A. R. M., & Ronco, C. (2013) · Blood Purification · doi:10.1159/000356369 · Cited by 24
What Happens to the Heart in Chronic Kidney Disease?
Rutherford, E., & Mark, P. B. (2017) · The Journal of the Royal College of Physicians of Edinburgh · doi:10.4997/jrcpe.2017.117 · Cited by 24
Lithovius, R., Harjutsalo, V., Mutter, S., Gordin, D., Forsblom, C. M., Groop, P., & FinnDiane Study Group (2020) · Diabetes Care · doi:10.2337/dc20-0170 · Cited by 23
The Attributable Burden of Hypertension: Focus on CKD
Jamerson, K., & Townsend, R. R. (2011) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2010.11.006 · Cited by 23
Self-citationTanner, R. M., Shimbo, D., Irvin, M. R., Spruill, T. M., Bromfield, S. G., Seals, S. R., Young, B. A., & Muntner, P. (2017) · Journal of Clinical Hypertension · doi:10.1111/jch.13065 · Cited by 23
Self-citationHypertension in Chronic Kidney Disease
Azancot, M. A., Ramos-Terrades, N., Moreso, F., Ibernón, M., Espinel, E., Torres, I. B., Fort, J., & Serón, D. (2014) · Transplantation · doi:10.1097/tp.0000000000000103 · Cited by 22
Hypertension Control and Antihypertensive Therapy in Patients With Chronic Kidney Disease
Unni, S. K., White, K., Goodman, M. J., Ye, X., Mavros, P., Bash, L. D., & Brixner, D. L. (2014) · American Journal of Hypertension · doi:10.1093/ajh/hpu215 · Cited by 22
Mancusi, C., Izzo, R., de Simone, G., Carlino, M., Canciello, G., Stabile, E., Luca, N. D., Trimarco, B., & Losi, M. (2018) · Nephrology, Dialysis and Transplantation · doi:10.1093/ndt/gfx062 · Cited by 20
Desai, N. K., Saraswathy, V. M., Hunter, K. M., & McFadden, C. B. (2013) · Journal of Clinical Hypertension · doi:10.1111/jch.12095 · Cited by 22
Pharmacogenomics of Hypertension in CKD: The CKD-PGX Study
Eadon, M. T., Maddatu, J., Moe, S. M., Sinha, A. D., Ferreira, R. M., Miller, B. W., Sher, S. J., Su, J., Pratt, V. M., Chapman, A. B., et al. (2021) · Kidney360 · doi:10.34067/kid.0005362021 · Cited by 21
Antihypertensive treatment and renal protection: Is there a J‐curve relationship?
Viazzi, F. C., Leoncini, G., Grassi, G. M., & Pontremoli, R. (2018) · Journal of Clinical Hypertension · doi:10.1111/jch.13396 · Cited by 20
Tegegne, B., Demeke, T., Ibro, S. A., Edmealem, A., & Ademe, S. (2020) · BioMed Research International · doi:10.1155/2020/5969326 · Cited by 21
Kula, A. J., Prince, D. K., Flynn, J. T., & Bansal, N. (2021) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020081156 · Cited by 20
Resistant hypertension: A stepwise approach
Yahr, J., Thomas, G., Calle, J., & Taliercio, J. J. (2023) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.90a.22046 · Cited by 23
Masuda, T., & Nagata, D. (2023) · Hypertension Research · doi:10.1038/s41440-023-01220-2 · Cited by 20
Mortality Burden and Life-Years Lost Across the Age Spectrum for Adults Living with CKD
Kula, A. J., Prince, D. K., Katz, R., & Bansal, N. (2023) · Kidney360 · doi:10.34067/kid.0000000000000097 · Cited by 19
Resistant Hypertension Updated Guidelines
Chernova, I., & Krishnan, N. (2019) · Current Cardiology Reports · doi:10.1007/s11886-019-1209-6 · Cited by 21
Prediction and Risk Stratification of Cardiovascular Disease in Diabetic Kidney Disease Patients
Ren, J., Liu, D., Li, G., Duan, J., Dong, J., & Liu, Z. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.923549 · Cited by 19
Pathogenesis of Drug-Resistant Hypertension
Townsend, R. R. (2014) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2014.08.004 · Cited by 19
Self-citationThiazides in advanced chronic kidney disease
Sinha, A. D., & Agarwal, R. (2015) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000188 · Cited by 19
Screening and Recognition of Chronic Kidney Disease in VA Health Care System Primary Care Clinics
Bansal, S., Mader, M. J., & Pugh, J. A. (2020) · Kidney360 · doi:10.34067/kid.0000532020 · Cited by 18
Tsuchida-Nishiwaki, M., Uchida, H., Takeuchi, H., Nishiwaki, N., Maeshima, Y., Saito, C., Sugiyama, H., Wada, J., Narita, I., Watanabe, T., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-94467-z · Cited by 18
Ding, J., Cui, S., Li, S. Y., Cui, L. Y., Nan, Q. Y., Lin, X. J., Xuan, M. Y., Jin, J., Piao, S. G., Jiang, Y. J., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0286903 · Cited by 19
RetractedNakanishi, M., Mizuno, T., Mizokami, F., Koseki, T., Takahashi, K., Tsuboi, N., Katz, M., Lee, J. K., & Yamada, S. (2020) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.13262 · Cited by 19
Peter, W. L. S., Farley, T. M., & Carter, B. L. (2011) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e32834902c8 · Cited by 18
Hameed, M. A., Freedman, J., Watkin, R. W., Ganeshan, A., & Dasgupta, I. (2017) · Clinical Kidney Journal · doi:10.1093/ckj/sfx066 · Cited by 18
Recent advances in the management of secondary hypertension: chronic kidney disease
Masuda, T., & Nagata, D. (2020) · Hypertension Research · doi:10.1038/s41440-020-0491-4 · Cited by 17
“Recently, the number of chronic kidney disease (CKD) patients has been globally increasing, and hypertension is the most common comorbidity in these patients [1].”
BackgroundPirasath, S., & Sundaresan, T. (2021) · SAGE Open Medicine · doi:10.1177/20503121211012497 · Cited by 20
Epidemiology and Risk Factors for Stroke in Chronic Kidney Disease: A Narrative Review
Kourtidou, C., & Τζιόμαλος, Κ. (2023) · Biomedicines · doi:10.3390/biomedicines11092398 · Cited by 17
Hypertension in Chronic Kidney Disease: Novel Insights
Duni, Α., Dounousi, E. C., Pavlakou, P., Eleftheriadis, T., & Liakopoulos, V. (2019) · Current Hypertension Reviews · doi:10.2174/1573402115666190415153554 · Cited by 17
Home Blood Pressure Monitoring in CKD
Cohen, D. L., Huan, Y., & Townsend, R. R. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.12.015 · Cited by 19
Self-citationKobayashi, K., Chin, K., Hatori, N., Furuki, T., Sakai, H., Miyakawa, M., Asayama, K., Eguchi, N., Katsuya, T., Tamura, K., et al. (2023) · Hypertension Research · doi:10.1038/s41440-023-01366-z · Cited by 16
“In the Chronic Renal Insuf fi ciency Cohort (CRIC) Study, 67.1% of patients had a target BP 140/90 mmHg and 46.1% had a target BP 130/ 80 mmHg [18].”
BackgroundInfluentialCurrent perspective on circadian function of the kidney
Benjamin, J. I., & Pollock, D. M. (2023) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00247.2023 · Cited by 18
Optimal blood pressure target and measurement in patients with chronic kidney disease
Kim, C., Choi, H.-S., Bae, E., Kim, S., & Ma, S. (2019) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2019.164 · Cited by 14
Tada, K., Maeda, T., Takahashi, K., Ito, K., Yasuno, T., Funakoshi, S., Satoh, A., Kawazoe, M., Yoshimura, C., Mukoubara, S., et al. (2021) · Clinical and Experimental Nephrology · doi:10.1007/s10157-021-02042-7 · Cited by 17
Association of Base Excision Repair Gene Polymorphisms with ESRD Risk in a Chinese Population
Cai, Z., Chen, H., Tao, J., Guo, W., Liu, X., Zheng, B., Wei, S., & Wang, Y. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/928421 · Cited by 15
Li, D., Huo, Z., Liu, D., Gong, N., Zhang, F., Kong, Y., Zhang, Y., Su, X., Xu, Q., Feng, J., et al. (2022) · Journal of Clinical Hypertension · doi:10.1111/jch.14455 · Cited by 15
Kitamura, H., Tanaka, S., Hiyamuta, H., Shimamoto, S., Tsuruya, K., Nakano, T., & Kitazono, T. (2022) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.63891 · Cited by 15
Zhang, J., Healy, H. G., Venuthurupalli, S. K., Tan, K., Wang, Z., Cameron, A. L., & Hoy, W. E. (2019) · BMC Nephrology · doi:10.1186/s12882-019-1532-6 · Cited by 15
Zhao, M., Wang, R., Yu, Y., Chang, M., Ma, S., Zhang, H., Qu, H., & Zhang, Y. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.638611 · Cited by 17
Sonawane, K., Qian, J., & Hansen, R. A. (2014) · Clinical Therapeutics · doi:10.1016/j.clinthera.2014.11.011 · Cited by 15
The Role of the Primary Care Physician in Managing Early Stages of Chronic Kidney Disease
Coritsidis, G., Linden, E. A., & Stern, A. S. (2011) · Postgraduate Medicine · doi:10.3810/pgm.2011.09.2473 · Cited by 15
Renal Denervation in Patients With Moderate to Severe Chronic Kidney Disease
Schlaich, M. P., Mahfoud, F., Böhm, M., Narkiewicz, K., Ruilope, L. M., Williams, B., Mancia, G., Sharif, F., Ribichini, F. L., Lung, T., et al. (2025) · Hypertension · doi:10.1161/hypertensionaha.125.25470 · Cited by 15
Chronic Kidney Disease Management in Developing Countries
Badro, D. A. (2023) · Springer eBooks · doi:10.1007/978-3-030-74786-2_27-1 · Cited by 18
Zhang, J., Wang, C., Gong, W., Ye, Z., Tang, Y., Zhao, W., Peng, H., & Lou, T. (2016) · Nephrology · doi:10.1111/nep.12839 · Cited by 14
Hyperkalemia in the Hypertensive Patient
Lakkis, J. I., & Weir, M. R. (2018) · Current Cardiology Reports · doi:10.1007/s11886-018-0954-2 · Cited by 15
Self-citationThromboxane A2 is involved in the development of hypertension in chronic kidney disease rats
Hu, J., Yang, Z., Chen, X., Kuang, S., Lian, Z., Ke, G., Liao, R., Ma, J., Li, S., Zhang, L., et al. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174435 · Cited by 14
Reinecke, H., Breithardt, G., Engelbertz, C., Schmieder, R., Fobker, M., Pinnschmidt, H., Schmitz, B., Bruland, P., Wegscheider, K., Pavenstädt, H., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148057 · Cited by 10
“In contrast, in cohorts mainly treated by nephrologists [30,34,35] the use of ACE inhibitors, ARBs and loop diuretics was markedly higher than in our registry, and moreover further increased with higher CKD stages.”
Evaluation and Treatment of Hypertension in End-Stage Renal Disease Patients on Hemodialysis
Buren, P. N. V. (2016) · Current Cardiology Reports · doi:10.1007/s11886-016-0805-y · Cited by 14
Discrepancies in Clinic and Ambulatory Blood Pressure in Korean Chronic Kidney Disease Patients
Oh, Y. K., Chin, H. J., Ahn, S. Y., An, J. N., Lee, J. P., Lim, C. S., & Oh, K. (2017) · Journal of Korean Medical Science · doi:10.3346/jkms.2017.32.5.772 · Cited by 14
Kudo, N., Yokokawa, H., Fukuda, H., Sanada, H., Miwa, Y., Hisaoka, T., & Isonuma, H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133641 · Cited by 14
Interdisciplinary Telehealth Team Positively Impacts Difficult-to-Control Hypertension in CKD
Dopp, J. M., Lange, A., & Maursetter, L. J. (2023) · Kidney360 · doi:10.34067/kid.0000000000000130 · Cited by 13
Mwasongwe, S. E., Tanner, R. M., Poudel, B., Pugliese, D. N., Young, B. A., Abdalla, M., Musani, S. K., Gutiérrez, O. M., Correa, A., Shimbo, D., et al. (2020) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08840719 · Cited by 13
Self-citationZheng, Y., Tang, L., Zhang, W., Zhao, D., Zhang, D. H., Zhang, L., Cai, G., Chen, X., Survey of Prevalence, A. A. T. R. I. C. K. D. P. W. H. I. C. (. C. G., Fu, P., et al. (2018) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfy301 · Cited by 13
Blood Pressure Control in CKD Patients: Why Do We Fail to Implement the Guidelines?
Becker, G. J., & Wheeler, D. C. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.12.013 · Cited by 14
Determinants of hypertension among diabetic patients in southern Ethiopia: a case-control study
Anjajo, E. A., Workie, S. B., Tema, Z. G., Woldegeorgis, B. Z., & Bogino, E. A. (2023) · BMC Cardiovascular Disorders · doi:10.1186/s12872-023-03245-4 · Cited by 17
Stompór, T. P., Adamczak, M., Kurnatowska, I., Naumnik, B., Nowicki, M. P., Tylicki, L., Winiarska, A., & Krajewska, M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12165184 · Cited by 15
Motiejūnaitė, J., Flamant, M., Arnoult, F., Lahens, A., Tabibzadeh, N., Boutten, A., Rouzet, F., Vrtovsnik, F., Vidal‐Petiot, E., & de Pinho, N. A. (2024) · Hypertension Research · doi:10.1038/s41440-024-01778-5 · Cited by 12
“Arterial hypertension is highly prevalent among patients with chronic kidney disease (CKD), occurring in more than 90% of patients with moderate to severe CKD [1, 2].”
Gaydarski, L., Dimitrova, I. N., Stanchev, S., Iliev, A. A., Kotov, G. N., Kirkov, V., Stamenov, N., Dikov, T. I., Georgiev, G. P., & Landzhov, B. V. (2024) · Biomedicines · doi:10.3390/biomedicines12081723 · Cited by 12
Greenberg, J. O., Vakharia, N., Szent‐Gyorgyi, L. E., Desai, S. P., Turchin, A., Forman, J. P., Bonventre, J. V., & Kachalia, A. B. (2013) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2012-001308 · Cited by 12
Liu, B., Wang, Q., Wang, Y., Wang, J., Zhang, L., Zhao, M., & On behalf of the C‐STRIDE study group (2019) · Journal of Clinical Hypertension · doi:10.1111/jch.13761 · Cited by 13
Pathophysiology of Hypertension in Chronic Kidney Disease
Huan, Y., Cohen, D. L., & Townsend, R. R. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-411602-3.00014-7 · Cited by 12
Self-citationKelly, D., Li, L., Burgess, A. I., Poole, D., DUERDEN, J. M., & Rothwell, P. M. (2020) · Stroke and Vascular Neurology · doi:10.1136/svn-2020-000422 · Cited by 12
He, H., Xiao, X., Yang, J., & Lei, M. (2024) · Scientific Reports · doi:10.1038/s41598-024-78307-4 · Cited by 11
Okpechi, I. G., Zaidi, D., Ye, F., Fradette, M., Schick‐Makaroff, K., Berendonk, C., Abdulrahman, A., Braam, B. G., Ghimire, A., Hariramani, V. K., et al. (2022) · Canadian Journal of Kidney Health and Disease · doi:10.1177/20543581221077500 · Cited by 12
Boggia, J. G., Silvariño, R., Luzardo, L., & Noboa, O. A. (2014) · Hypertension Research · doi:10.1038/hr.2014.82 · Cited by 11
Ambulatory Arterial Stiffness Index and circadian blood pressure variability
Bahrainwala, J. Z., Patel, A. M., Diaz, K. M., Veerabhadrappa, P., Cohen, D. L., Cucchiara, A. J., & Townsend, R. R. (2015) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2015.07.001 · Cited by 12
Self-citationKaboré, J., Metzger, M., Helmer, C., Berr, C., Tzourio, C., Drüeke, T. B., Massy, Z. A., & Stengel, B. (2016) · Kidney International Reports · doi:10.1016/j.ekir.2016.10.006 · Cited by 11
Feriozzi, S., Battaglia, Y., Cirami, C. L., Gangemi, C., Manna, G. L., Gesualdo, L., Muiesan, M. L., Pani, A., Pieruzzi, F., Ribichini, F. L., et al. (2025) · Journal of Nephrology · doi:10.1007/s40620-025-02406-2 · Cited by 11
Blood pressure targets for hypertension in people with chronic renal disease
Erviti, J., Saiz, L. C., Leache, L., Pijoán, J. I., Orenga, M. M., Salzwedel, D. M., & Méndez-López, I. (2024) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008564.pub3 · Cited by 10
Managing Hypertension in Chronic Kidney Disease: The Role of Diet and Guideline Recommendations
Stambolliu, E., Iliakis, P., Tsioufis, K. P., & Damianaki, A. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14113755 · Cited by 11
Hydrogen sulfide in health and diseases: cross talk with noncoding RNAs
Lu, Q.-B., Ding, Y., Fu, X. Y., Sun, H., & Zhang, J. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00507.2022 · Cited by 10
Lv, J., Guo, L., Wang, R., & Chen, J. (2023) · Kidney Diseases · doi:10.1159/000530395 · Cited by 12
Evaluation of hypertension related knowledge, attitudes and practices at community level in Kabul
Bashaar, M., Saleem, F., Thawani, V., Hassali, M. A., & Hashemi, T. (2019) · Pharmacy & Pharmacology International Journal · doi:10.15406/ppij.2019.07.00239 · Cited by 10
Bazzi, C., Seccia, T. M., Napodano, P., Campi, C., Caroccia, B., Cattarin, L., & Calò, L. A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061656 · Cited by 10
Metadata
- Authors
- Muntner, P., Anderson, A., Charleston, J., Chen, Z., Ford, V., Makos, G., O'Connor, A., Perumal, K., Rahman, M., Steigerwalt, S., Teal, V., Townsend, R., Weir, M., & Wright, J. T.
- Affiliations
- University of Alabama at Birmingham (US)
- University of Pennsylvania (US)
- University of Maryland, Baltimore (US)
- National Institutes of Health (US)
- University of Illinois Chicago (US)
- University Hospitals Cleveland Medical Center (US)
- St. John Medical Center (US)
- Case Western Reserve University (US)
- Corresponding author
- Muntner, Paul
- ORCID
- Venue
- American Journal of Kidney Diseases
- Publisher
- Elsevier BV
- Published
- 2010-03
- Volume
- 55
- Issue
- 3
- Pages
- 441-451
- ISSN
- 0272-6386 (ISSN-L)
- PMC
- PMC2866514
- OpenAlex
- W2096512601
- Cited by
- 423
- References
- 16
- Citations by year
- 2026: 10 · 2025: 34 · 2024: 32 · 2023: 45 · 2022: 34 · 2021: 35 · 2020: 33 · 2019: 40 · 2018: 32 · 2017: 23 · 2016: 20 · 2015: 19 · 2014: 13 · 2013: 16 · 2012: 17
- FWCI
- 7.55
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- American Journal of Kidney Diseases (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (5U01DK06102, U01DK060990, 5U01 DK60980, T32DK007785, T32DK060455, K01DK064860, U01DK060984, U01DK060902, U01DK060980, U01DK060963, U01DK061021, U01DK061028)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
- Keywords
- hypertension, chronic kidney disease, blood pressure control, hypertension awareness, antihypertensive medication use, ACE inhibitors, angiotensin receptor blockers, urinary albumin excretion, Chronic Renal Insufficiency Cohort Study, older adults, racial disparities
- MeSH terms
- Adult, Aged, Chronic Disease, Female, Humans, Hypertension, Kidney Diseases, Male, Middle Aged, Renal Insufficiency, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review